<?xml version="1.0" encoding="UTF-8"?>
<ref id="B17-viruses-12-00703">
 <label>17.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Musharrafieh</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Ma</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Smee</surname>
    <given-names>D.F.</given-names>
   </name>
   <name>
    <surname>DeGrado</surname>
    <given-names>W.F.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses</article-title>
  <source>Antivir. Res.</source>
  <year>2017</year>
  <volume>140</volume>
  <fpage>45</fpage>
  <lpage>54</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2017.01.006</pub-id>
  <pub-id pub-id-type="pmid">28087313</pub-id>
 </element-citation>
</ref>
